STAAR Surgical Cash Flow from Investing Activities 2010-2025 | STAA
STAAR Surgical cash flow from investing activities from 2010 to 2025. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
STAAR Surgical Annual Cash Flow Investing
(Millions of US $) |
| 2024 |
$-59 |
| 2023 |
$74 |
| 2022 |
$-156 |
| 2021 |
$-14 |
| 2020 |
$-8 |
| 2019 |
$-10 |
| 2018 |
$-2 |
| 2017 |
$-1 |
| 2016 |
$-3 |
| 2015 |
$-2 |
| 2014 |
$-4 |
| 2013 |
$-3 |
| 2012 |
$-2 |
| 2011 |
$-1 |
| 2010 |
$19 |
| 2009 |
$-8 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.906B |
$0.314B |
|
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
|
